Global Blood Therapeutics (GBT) broke out to new highs last week and remains strong today. Let's check out the charts of this clinical-stage biopharmaceutical company.
More from Investing
These names are showing both technical and quantitative deterioration.
If you want to stay busy and make some money then you need to adapt to the action.
Markets appear to be pricing in a lot of bad short-term news for richly-valued companies such as Tesla, but perhaps not much risk related to potential longer-term macro headwinds.